LungLB in Subjects Presenting With Indeterminate Pulmonary Nodules

NCT05171491 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 425

Last updated 2024-06-13

No results posted yet for this study

Summary

Correlate performance of LungLB Test with outcome of a scheduled biopsy.

Conditions

  • Solitary Pulmonary Nodule
  • Multiple Pulmonary Nodules

Sponsors & Collaborators

  • LungLife AI

    lead INDUSTRY

Principal Investigators

  • Michael Donovan, MD · LungLife AI

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-26
Primary Completion
2023-12-30
Completion
2024-09-02

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05171491 on ClinicalTrials.gov